Latest Breaking News On - படைப்பு அழிவு ஆய்வகம் - Page 2 : comparemela.com

OrganoTherapeutics successfully participated in Creative Destruction Lab (CDL) program Founder Jens Schwamborn and Javier Jarazo of OrganoTherapeutics successfully participate in the Creative Destruction Lab program. OrganoTherapeutics is a drug discovery start-up pioneering the development of patient-specific midbrain organoids. These are simplified, miniaturized replicas of the human brain that are grown in vitro in the laboratory. The background is research into Parkinson’s disease and the development of new drugs, as there are currently no truly curative treatments for this disease. With the patient-specific midbrain organoids, Jens Schwamborn and Javier Jarazo are able to develop new small-molecule drugs that target neurodegeneration in Parkinson’s disease. At the same time, the mini-brains can also be used to develop other neurodegenerative treatments. However, the cost for research is high, which is why OrganoTherapeutics relies on support to move the research forward �

Jens schwambornJavier jarazoCreative destruction labFounder jens schwambornArtificial intelligenceDes hauts fourneauxபடைப்பு அழிவு ஆய்வகம்செயற்கை உளவுத்துறை